An insurance policy, relating to a drug clinical trial protocol, examined by an ethics committee limits the insurer liability to any damage or injury caused directly or indirectly or just in connection with any Coronavirus. According to the Italian law, such provision shall be considered inadmissible. Should an experimental protocol be approved with such a limit of liability, the participants involved in the trial, the healthcare institution in which it takes place and any healthcare personnel involved must be informed in detail.
INSURANCE POLICIES TO PROTECT PARTICIPANTS IN DRUG CLINICAL TRIALS AND LIMIT OF LIABILITY FOR DAMAGES RELATED TO COVID-19 INFECTION
Rodriguez D.Membro del Collaboration Group
;Aprile AMembro del Collaboration Group
2021
Abstract
An insurance policy, relating to a drug clinical trial protocol, examined by an ethics committee limits the insurer liability to any damage or injury caused directly or indirectly or just in connection with any Coronavirus. According to the Italian law, such provision shall be considered inadmissible. Should an experimental protocol be approved with such a limit of liability, the participants involved in the trial, the healthcare institution in which it takes place and any healthcare personnel involved must be informed in detail.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
admin-unitn-16+MORESCHI,+RODRIGUEZ,+APRILE_ok.pdf
accesso aperto
Tipologia:
Published (publisher's version)
Licenza:
Accesso libero
Dimensione
149.11 kB
Formato
Adobe PDF
|
149.11 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
